A Double-Blind, Placebo-Controlled Study of Quetiapine and Lithium Monotherapy in Adults in the Acute Phase of Bipolar Depression (EMBOLDEN I)
The DOI matches its Crossref record.
Abstract
OBJECTIVE: The aim of this study was to compare the efficacy and tolerability of quetiapine and lithium monotherapy with that of placebo for a major depressive episode in bipolar disorder. METHOD: 802 patients with DSM-IV-defined bipolar disorder (499 bipolar I, 303 bipolar II) were randomly allocated to quetiapine 300 mg/d (n = 265), quetiapine 600 mg/d (n = 268), lithium 600 to 1800 mg/d (n = 136), or placebo (n = 133) for 8 weeks. Primary endpoint was the change in Montgomery-Asberg Depression Rating Scale (MADRS) total score. The study was conducted from August 2005 to May 2007. RESULTS: Mean MADRS total score change from baseline at week 8 was -15.4 for quetiapine 300 mg/d, -16.1 for quetiapine 600 mg/d, -13.6 for lithium, and -11.8 for placebo (P < .001 for both quetiapine doses, P = .123 for lithium, vs placebo). Quetiapine 600 mg/d was significantly more effective than lithium in improving MADRS total score at week 8 (P = .013). Quetiapine-treated (both doses), but not lithium-treated, patients showed significant improvements (P < .05) in MADRS response and remission rates, Hamilton Depression Rating Scale (HDRS), Clinical Global Impressions-Bipolar-Severity of Illness and -Change, and Hamilton Anxiety Rating Scale (HARS) scores at week 8 versus placebo. Both quetiapine doses were more effective than lithium at week 8 on the HDRS and HARS. The most common adverse events were somnolence, dry mouth, and dizziness with quetiapine (both doses) and nausea with lithium. CONCLUSIONS: Quetiapine (300 or 600 mg/d) was more effective than placebo for the treatment of episodes of acute depression in bipolar disorder. Lithium did not significantly differ from placebo on the main measures of efficacy. Both treatments were generally well tolerated. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00206141.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The latter finding must be reconciled with the fact that quetiapine beat placebo in only three of the five individual trials in patients with BDII, compared to all five in patients with BDI.253, 290, 438, 439, 440”
Citations
Cites
Still being checked.
Cited by
Items 201–300 of 387
Management of Bipolar Depression
Chang, J. S., & Ha, K. (2011) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.85390 · Cited by 8
Drug safety evaluation of olanzapine/fluoxetine combination
Cristancho, M. A., & Thase, M. E. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.933804 · Cited by 7
Quetiapine is effective in the treatment of adults in the acute phase of bipolar depression
Grunze, H. (2010) · Evidence-Based Mental Health · doi:10.1136/ebmh.13.3.88 · Cited by 6
Porcelli, S., Balzarro, B., Ronchi, D. D., & Serretti, A. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000103 · Cited by 6
Penders, T. M., Rohaidy, R., & Agarwal (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s43113 · Cited by 6
Wu, C., Chen, X., Lai, J., Xu, Y., & Hu, S. (2020) · Medicine · doi:10.1097/md.0000000000020981 · Cited by 7
Spanemberg, L., Massuda, R., Lovato, L. M., Paim, L. L., Vares, E. A., da Rocha, N. S., & Ceresér, K. M. M. (2011) · Psychiatric Quarterly · doi:10.1007/s11126-011-9191-1 · Cited by 7
Miola, A., Tondo, L., & Baldessarini, R. J. (2022) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001601 · Cited by 5
A quetiapina: 3 medicamentos em uma única molécula: uma breve revisão e atualização
Caixeta, L. F., Vargas, C. M., Nogueira, Y. L., Baldaçara, L., Alfaia, S. M. M. D. R., Rabahi, A., & Caixeta, V. D. M. (2023) · Debates em Psiquiatria · doi:10.25118/2763-9037.2023.v13.1054 · Cited by 8
Fredskild, M. U., Bruun, C. F., Vinberg, M., Faurholt‐Jepsen, M., Kessing, L. V., & Munkholm, K. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.04.125 · Cited by 7
Gao, K., Kemp, D. E., Wu, R., & Calabrese, J. R. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch105 · Cited by 9
Spelber, D., Almeida, J., & Nemeroff, C. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00019-0 · Cited by 5
Unmet Needs in Psychiatry: Bipolar Depression
Baldessarini, R. J., Tondo, L., & Vázquez, G. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-42637-8_4 · Cited by 8
Tao, H., Wang, J., Shen, D., Sun, F., & Jin, W. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.850021 · Cited by 6
Chapter 49. Treatment of Bipolar Disorder
Strakowski, S. M., & Keck, P. E. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as49 · Cited by 5
Park, D. Y., Goffin, K. C., Shah, S., Yuen, L. D., Holtzman, J. N., Hooshmand, F., Miller, S., Wang, P. W., & Ketter, T. A. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.01.016 · Cited by 5
Anastopoulou, Z., Sazakli, E., Bouzoukas, C., Kostakis, M. G., Leotsinidis, M., Τhomaidis, Ν. S., & Vantarakis, A. (2026) · International Journal of Environmental Research · doi:10.1007/s41742-025-01027-8 · Cited by 6
Yalın, N., Yildiz, A., Siafis, S., Vieta, E., & Leucht, S. (2026) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2026.112818 · Cited by 6
Can Quetiapine Prolong the Antidepressant Effect of Ketamine? A 5-Year Follow-up Study
Amiaz, R., Saporta, R., Noy, A., Berkenstadt, H., & Weiser, M. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001489 · Cited by 4
Tercer Consenso Argentino sobre el manejo de los Trastornos Bipolares. Segunda Parte B
Cetkovich, M., Abadi, A. F., Camino, S., Bonetto, G. G., Herbst, L., Marengo, E., Torrente, F. M., Maresca, T., Bustin, J., Morra, C. A., et al. (2023) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v34i160.459 · Cited by 5
Les recommandations professionnelles dans le traitement de la dépression bipolaire
Samalin, L., Charpeaud, T., & Guillaume, S. (2011) · L Encéphale · doi:10.1016/s0013-7006(11)70057-4 · Cited by 4
Qualitative study of Patients’ preferences for Bipolar Depression Treatment
Ng‐Mak, D., Poon, J. L., Rajagopalan, K., Kleinman, L., Roberts, L., Revicki, D. A., & Loebel, A. D. (2015) · Value in Health · doi:10.1016/j.jval.2015.03.718 · Cited by 4
Progress and trends of research on mineral elements for depression
Gao, B., Li, C., Qu, Y., Cai, M., Zhou, Q., Zhang, Y., Lu, H., Tang, Y., Li, H., & Shen, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35469 · Cited by 7
An Overview of Machine Learning Applications in Mood Disorders
Topolski, N., Jeong, S. H., & Mwangi, B. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.017 · Cited by 4
Ketiyapin ile Tedavi Edilen Olfaktör Referans Sendromlu Bir Olgu Sunumu
Atmaca, M., Korkmaz, S., Namlı, M. N., Korkmaz, H., & Kuloğlu, M. (2011) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20110415053148 · Cited by 4
Bipolar depression: Managing patients with second generation antipsychotics
Avery, L. M., & Drayton, S. J. (2016) · The International Journal of Psychiatry in Medicine · doi:10.1177/0091217416636576 · Cited by 4
Pharmacological treatment of bipolar depression
Young, A. H., & Nemeroff, C. B. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511776922.004 · Cited by 3
Self-citationAntipsicóticos para la depresión bipolar: la paradoja
Pacchiarotti, I. (2015) · Psiquiatría Biológica · doi:10.1016/s1134-5934(15)30007-5 · Cited by 3
DeJongh, B. M. (2012) · Mental Health Clinician · doi:10.9740/mhc.n110748 · Cited by 3
Fountoulakis, K. N. (2014) · Springer eBooks · doi:10.1007/978-3-642-37216-2_16 · Cited by 3
Wang, Y., Liu, J., Zhang, R., Luo, G., & Sun, D. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-024-02876-x · Cited by 3
Tay, J. L., Li, Z., Xu, C., & Zhenyu, Z. H. O. U. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112557 · Cited by 3
Mood Disorders: Brain Imaging and Therapeutic Implications
(2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018 · Cited by 3
Emerging drugs for bipolar depression: an update
Keedwell, P. A., & Young, A. H. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.872628 · Cited by 3
Self-citationClinical Management of Older Age Bipolar Disorder
Dols, A., Chan, M. Y. S., & Shulman, K. I. (2017) · Springer eBooks · doi:10.1007/978-3-319-48912-4_4 · Cited by 3
Korean Medication Algorithm Project for Bipolar Disorder 2022: Depressive Episode
Seo, J. S., Woo, Y. S., Bahk, W., Jeong, J., Yoon, B.-H., Choo, I. H., Yang, C.-M., Kim, W., Lee, J. G., Shim, S.-H., et al. (2022) · 신경정신의학 · doi:10.4306/jknpa.2022.61.2.123 · Cited by 2
Use of lithium in psychiatric, viral and neurological disorders - a review
Denys, B., Góra, K., Zdziennicki, W., Zimnicki, P., Lato, M., Iberszer, K., Litwiniuk, M., Zaniuk, M., HURKAŁA, K., & ANTONIK, D. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.18.01.013 · Cited by 2
Llorca, P. (2011) · L Encéphale · doi:10.1016/s0013-7006(11)70055-0 · Cited by 2
Licht, R. W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-405170-6.00010-5 · Cited by 2
Neuroimaging Studies of Effects of Psychotherapy in Depression
Bauer, I. E., & Meyer, T. D. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.021 · Cited by 2
Janjun, M. R. H. (2023) · AIP conference proceedings · doi:10.1063/5.0163388 · Cited by 2
Actualización en el uso y el manejo del litio en neuropsiquiatría
Corrales, A., Cetkovich, M., Abadi, A. F., Camino, S., Bonetto, G. G., Mato, A. M. L., Marengo, E., Abraham, E., Maresca, T., Bagnati, P. R. A. D. N., et al. (2024) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v34i162.504 · Cited by 2
Correll, C. U., Durgam, S., Kozauer, S. G., Lakkis, H. D., Chen, C., Vanover, K. E., Mates, S. L., & Davis, R. E. (2025) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000597 · Cited by 4
Qi, C., Wu, Y., Fan, Y., Li, Y., Wang, Z., & Zhu, H. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119982 · Cited by 4
How can we classify “mood stabilizers” with different properties?
Kondo, T. (2011) · Clinical Neuropsychopharmacology and Therapeutics · doi:10.5234/cnpt.2.12 · Cited by 2
Korean Medication Algorithm for Bipolar Disorder 2014: Depressive Episode
Seo, J. S., Bahk, W. M., Lee, J. G., Woo, Y. S., Jeong, J. H., Wang, H. R., Kim, M.-D., Sohn, I., Shim, S. H., Min, K. J., et al. (2014) · 대한정신약물학회지 · Cited by 3
Eficacia de quetiapina de liberación prolongada en la sintomatología afectiva
Álamo, C., & Lopez-Munoz, F. J. (2012) · Revista de Psiquiatría y Salud Mental · doi:10.1016/s1888-9891(12)70012-5 · Cited by 2
Efficacy of Olanzapine for Treating Depressive Episodes in Bipolar Disorder
Kirino, E. (2014) · Clinical Neuropsychopharmacology and Therapeutics · doi:10.5234/cnpt.5.11 · Cited by 2
Psychopharmacology of Bipolar II Depression and Bipolar Depression with Mixed Features
Hsin, H., & Suppes, T. M. (2014) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.12.2.136 · Cited by 2
What's Up with Bipolar Disorder?
Suppes, T. M. (2011) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.9.4.foc415 · Cited by 2
Pharmacological Treatment Strategies for Acute Bipolar Depression
Kim, S. J. (2018) · 신경정신의학 · doi:10.4306/jknpa.2018.57.4.287 · Cited by 2
Electrophysiological Biomarkers for Mood Disorders
Ramakrishnan, N., Murphy, N., Selvaraj, S., & Cho, R. Y. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.015 · Cited by 2
Gründer, G. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_55 · Cited by 2
Rakofsky, J. J., Lucido, M. J., & Dunlop, B. W. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.04.035 · Cited by 3
Lopez-Munoz, F. J., D’Ocón, P., Romero, A., Guerra, J. A., Berardis, D. D., & Álamo, C. (2024) · Mental Illness · doi:10.1155/2024/8848525 · Cited by 1
Shafiq, S., Ronksley, P. E., Elliott, M. J., Bulloch, A. G. M., & Patten, S. B. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437251355643 · Cited by 2
Yatham, L. N., Kozauer, S. G., Earley, W. R., Huo, J. C., & Durgam, S. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121499 · Cited by 1
Huan, Y., Xu, N., Yang, R., Liuyan, Z., Wang, K., Huairong, W., Wu, J., Shuting, X., Chen, Y., Teng, L., et al. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121966 · Cited by 1
Cordell, W. G., Herbst, C., Kelsey, T., Melton, B. L., & Moeller, K. E. (2026) · Mental Health Clinician · doi:10.9740/mhc.2026.06.129 · Cited by 1
Recommandations thérapeutiques relatives aux troubles bipolaires
Hasler, G., Preisig, M., Müller, T., HolsboerTrachsler, E., Conus, P., Aubry, J., & Greil, W. (2011) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/fms.2011.07503 · Cited by 1
Lithium and Its Role in Psychiatry
Kamali, M., Ostacher, M. J., & Perlis, R. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-11844-9.00053-9 · Cited by 1
Pharmacological treatment of acute bipolar depression
Sachs, G. S., Sylvia, L. G., & Lund, H. G. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8567-5_9 · Cited by 1
Bipolar disorder: a review of current U.S. Food and Drug Administration approved pharmacotherapy
Shah, A., Yadav, P. P., Chaudhari, M. A., RAI, J., & Kantharia, N. D. (2015) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20150362 · Cited by 1
Samalin, L., & Llorca, P. (2014) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2014.02.007 · Cited by 2
Indications curative et préventive dans le trouble bipolaire
Pitchot, W. (2014) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2014.02.008 · Cited by 1
The role of antipsychotics and mood stabilizers in the treatment of bipolar disorder
Correll, C. U. (2011) · Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology · Cited by 2
The use of atypical antipsychotic drugs in Bipolar II disorder
Vieta, E., & Cruz, N. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003315.013 · Cited by 1
Current status of mood stabilisers in the management of Bipolar II disorder
Hadjipavlou, G. A., Bond, D. J., & Yatham, L. N. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003315.012 · Cited by 1
İki uçlu depresyonun farmakolojik tedavisinde yenilikler
Bez, Y. (2013) · Journal of Mood Disorders · Cited by 4
Mc, M., Rovera, C., Ciappolino, V., Di Pace, C., Paletta, S., Reggiori, A., & Ac, A. (2016) · Dual Diagnosis Open Access · doi:10.21767/2472-5048.100021 · Cited by 1
Pharmacological Treatment of the Maintenance Phase of Bipolar Depression: Efficacy and Side Effects
Gao, K., Wu, R., & Calabrese, J. R. (2016) · Milestones in drug therapy · doi:10.1007/978-3-319-31689-5_10 · Cited by 3
Essential Pharmacotherapies for Bipolar Disorder
Ruegg, H., Adler, C. M., Durán, L. R. P., Watson, S., & DelBello, M. P. (2019) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-018-0162-0 · Cited by 1
Mackin, P., & Young, A. H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-7020-3397-1.00021-5 · Cited by 1
Self-citationBrain Imaging and the Mechanisms of Antidepressant Action
Godlewska, B. R., Selvaraj, S., & Cowen, P. J. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.020 · Cited by 1
Effects of Lithium on Brain Structure in Bipolar Disorder
Kaur, J., Kafantaris, V., & Szeszko, P. R. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.018 · Cited by 1
Functional Connectome in Bipolar Disorder
Cha, J., & Anand, A. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.008 · Cited by 1
Diagnostik und Therapie bipolarer Störungen
Beier, F., Severus, E., & Bauer, M. (2020) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-020-1516-x · Cited by 1
Self-citationLewitzka, U., & Haußmann, R. (2022) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-021-2201-4 · Cited by 2
Bauer, M., Severus, E., & Laux, G. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_68 · Cited by 1
Self-citationMedikamente zur Behandlung bipolarer affektiver Störungen
Benkert, O. (2014) · Springer eBooks · doi:10.1007/978-3-642-54769-0_2 · Cited by 1
Lithium in Psychiatric Indications
Schefft, C., Volkmann, C., & Köhler, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_447 · Cited by 1
Maintenance Treatments of Lithium, Carbamazepine, and Adjunctive CBT in Bipolar Disorder: Review
Cong, F. (2023) · Lecture Notes in Education Psychology and Public Media · doi:10.54254/2753-7048/7/20220721 · Cited by 1
Sixty-year history of dopaminergic mechanism of antipsychotic drugs
RYBAKOWSKI, J. K. (2023) · Pharmacotherapy in Psychiatry and Neurology · doi:10.5114/fpn.2023.127421 · Cited by 4
Management of Mental Health Disorders in Pregnancy
Grosse, D. G., & Aggarwal, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-36490-7_31 · Cited by 1
Goñi, J. M. R., Castilla‐Rodríguez, I., Valcárcel‐Nazco, C., Castresana, C. D. L. C., Mar, J., & Aguilar, P. S. (2015) · PharmacoEconomics Spanish Research Articles · doi:10.1007/s40277-015-0042-6 · Cited by 1
Keßler, U. (2014) · NVA (Nasjonalt vitenarkiv) · Cited by 2
Evidence-based pharmacotherapy of bipolar disorder
Taylor, M. J., & Geddes, J. R. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511910395.004 · Cited by 1
Toniolo, R. A. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-07122016-150647 · Cited by 2
Katzman, M. A., Bleau, P., Blier, P., Chokka, P. R., Kjernisted, K. D., & Ameringen, M. V. (2023) · doi:10.32920/14638581.v1 · Cited by 1
Innovation in the Treatment of Bipolar Depression
El‐Mallakh, R. S. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14com09351
McGrath, P. J., & Roose, S. P. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.004
Advances in the Pharmacotherapy of Bipolar Affective Disorder
Kumar, A., Kamatchi, R., Marzanski, M., & Somashekar, B. (2012) · InTech eBooks · doi:10.5772/30188
Quetiapine in Bipolar Disorder
Kunz, M., Nyberg, S., & Yatham, L. N. (2011) · Wiley eBooks · doi:10.1002/9780470975114.ch10
Alberdi, G., & Manuel, J. (2012) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Managing bipolar depression: a therapeutic challenge?
Feetam, C. (2011) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.218
Comprehensive Pharmacologic Management of Bipolar Depression
McGirr, A., & Bond, D. J. (2014) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-014-0017-2
Benkert, O., Hautzinger, M., Graf-Morgenstern, M., Paulzen, M., & Himmerich, H. (2016) · Springer eBooks · doi:10.1007/978-3-662-49092-1_15
Uso de Antidepresivos y Suicidio en el Trastorno Bipolar
Fourcade, U., & Pablo, J. (2013) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Metadata
- Authors
- Young, A. H., McElroy, S. L., Bauer, M., Philips, N., Chang, W., Olausson, B., Paulsson, B., Brecher, M., & EMBOLDEN I (Trial 001) Investigators
- Affiliations
- University of British Columbia (CA)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2010-01-26
- Volume
- 71
- Issue
- 02
- Pages
- 150-162
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2028449820
- Cited by
- 390
- References
- 0
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 18 · 2023: 26 · 2022: 13 · 2021: 38 · 2020: 21 · 2019: 12 · 2018: 21 · 2017: 14 · 2016: 24 · 2015: 24 · 2014: 36 · 2013: 29 · 2012: 33
- FWCI
- 25.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- quetiapine, lithium, bipolar depression, bipolar disorder, atypical antipsychotics, monotherapy, acute depression, antidepressant efficacy, tolerability, sleepiness, nausea, depression remission, dose comparison, bipolar I disorder, bipolar II disorder, anxiety symptoms, mood stabilizers, placebo comparison, Montgomery-Asberg Depression Rating Scale, Hamilton Depression Rating Scale
- MeSH terms
- Quetiapine Fumarate, Adolescent, Adult, Aged, Antidepressive Agents, Bipolar Disorder, Dibenzothiazepines, Double-Blind Method, Female, Humans, Male, Middle Aged, Placebos, Psychiatric Status Rating Scales, Severity of Illness Index, Treatment Outcome, Lithium Compounds, Antimanic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.